PRO-DEX, INC. Total Long-Term Debt
PRO-DEX, INC. (PDEX) had Total Long-Term Debt of $17.51 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2026-09-03
- 2026-06-30: Long-term Debt $17.51M.
- 2025-06-30: Long-term Debt $15.43M.
- 2024-06-30: Long-term Debt $11.96M.
- 2023-06-30: Long-term Debt $12.80M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $17.51M 10-K · filed 2026-09-03 |
| 2025-06-30 | $15.43M 10-K · filed 2025-09-04 |
| 2024-06-30 | $11.96M 10-K · filed 2024-09-05 |
| 2023-06-30 | $12.80M 10-K · filed 2023-10-13 |
| 2022-06-30 | $13.59M 10-K · filed 2022-09-08 |
| 2021-06-30 | $12.84M 10-K · filed 2021-09-09 |
| 2020-06-30 | $3.98M 10-K · filed 2020-09-10 |
| 2019-06-30 | $4.60M 10-K · filed 2019-09-12 |
| 2013-03-31 | $403.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $389.00K 10-Q · filed 2013-02-13 |
| 2012-09-30 | $391.00K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $393.00K 10-Q · filed 2013-05-13 |
| 2012-03-31 | $954.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $1.04M 10-Q · filed 2012-02-07 |
| 2011-09-30 | $1.13M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $1.22M 10-K · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |